LMS Completes Software Code Development
January 08 2007 - 11:41AM
PR Newswire (US)
MONTREAL, QC, Jan. 8 /PRNewswire-FirstCall/ -- LMS Medical Systems
(AMEX:LMZ; TSX:LMZ), a healthcare technology company and developer
of the CALM(TM) clinical information system and risk management
software tools for obstetrics, today announced it has completed the
programming phase of the interoperability components for the
private label OB solution under development for McKesson Provider
Technologies, which private label development project has been
previously disclosed. Completion of the software bridge enables a
seamless flow of administrative and clinical information between
the LMS system and Horizon Clinical centralized patient record
management and medication management system functionality.
End-to-end hospital-wide operations, improved understanding of
clinical complexities and end-user sensitivity and support will
combine to address a maternal-fetal care solution supporting
improved patient safety and positive outcomes for both mothers and
their infants. "While the development process has been extensive,
the outcome is a product that provides radical workflow
improvement, delivering a seamless yet comprehensive solution for
overburdened OB clinical staff," said Diane Cote, LMS President
& CEO. "Congratulations are in order to the development
counterparties at both companies for their creativity and
dedication." Quality assurance is now being carried out to be
immediately followed by early field implementation. Once completed,
the product will in turn be released to the marketplace. ABOUT LMS
LMS is a leader in the application of advanced mathematical
modeling and neural networks for medical use. The LMS CALM(TM)
Decision Support Suite provides physicians, nursing staff, risk
managers and hospital administrators with clinical information
systems and risk management tools designed to improve outcomes and
patient care for mothers and their infants during labor and
delivery. Except for historical information contained herein, the
matters discussed in this news release are forward-looking
statements. Because these forward-looking statements involve risks
and uncertainties, there are important factors that could cause
actual results to differ materially from those expressed implied by
the forward-looking statements including, but without limitation,
economic conditions in general and in the healthcare market, the
demand for and market for our products in domestic and
international markets, our current dependence on the CALM product
suite, the challenges associated with developing new products and
obtaining regulatory approvals if necessary, research and
development activities, the uncertainty of acceptance of our
products by the medical community, the lengthy sales cycle for our
products, third party reimbursement, competition in our markets,
including the potential introduction of competitive products by
others, our dependence on our distributors, physician training,
enforceability and the costs of enforcement of our patents,
potential infringements of our patents and the other factors set
forth from time to time in the Company's filings with the United
States Securities and Exchange Commission and with the Canadian
Securities Commissions. The Company has no intention of or
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.
DATASOURCE: LMS MEDICAL SYSTEMS INC. CONTACT: Andrea Miller,
Communications, LMS Medical Systems Inc., (514) 488-3461 Ext. 222,
Fax: (514) 488-1880, ; http://www.lmsmedical.com/; David Gordon or
Grant Howard, The Howard Group Inc., Toll Free: 1-888-221-0915, ;
http://www.howardgroupinc.com/
Copyright